Skip to main navigation Skip to search Skip to main content

Granulocyte colony-stimulating factor and an in vitro whole blood model of melioidosis

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The study reported here was conducted in order to explore the mechanism of action of granulocyte colony-stimulating factor (G-CSF) in the treatment of Burkholderia pseudomallei infections (otherwise known as melioidosis). Use of G-CSF as an adjunct to antibiotics has been associated with decreasing mortality among patients with melioidosis in the tropical region of the Northern Territory of Australia. However, using an in vitro whole blood assay, no significant difference was detected in the bactericidal activity of samples obtained from dialysis patients, patients with type 2 diabetes mellitus and healthy controls, and there was no improvement following coincubation with G-CSF.

Original languageEnglish
Pages (from-to)205-207
Number of pages3
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume23
Issue number3
DOIs
Publication statusPublished - Mar 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this